| Sue C Eng, MD | |
|
11800 Ne 128th St, Suite 100, Kirkland, WA 98034-7208 | |
| (425) 899-4500 | |
| (425) 899-4510 |
| Full Name | Sue C Eng |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 28 Years |
| Location | 11800 Ne 128th St, Kirkland, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184603425 | NPI | - | NPPES |
| 0158432 | Other | WA | LABOR AND INDUSTRIES |
| 1004246 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00037348 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Evergreenhealth Medical Center | Kirkland, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Puget Sound Gastroenterology Pllc | 1759278252 | 57 |
News Archive
The Cautious Patient Foundation, the outreach and educational arm of PatientAlwaysFirst, a nonprofit organization committed to educating and empowering patients in the quest for quality health care, today announces a new grants program to support initiatives that successfully move patients towards greater engagement in their personal or family healthcare process.
New research from the University of Bristol shows that the experiences of work and family life for women in the UK have become increasing polarised between those with further education and those without. Over time, the material advantages of better-educated mothers, for themselves and for their children, have been increasing.
A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings, according to a study presented October 19, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
› Verified 8 days ago
| Entity Name | Puget Sound Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689646838 PECOS PAC ID: 1759278252 Enrollment ID: O20040301000478 |
News Archive
The Cautious Patient Foundation, the outreach and educational arm of PatientAlwaysFirst, a nonprofit organization committed to educating and empowering patients in the quest for quality health care, today announces a new grants program to support initiatives that successfully move patients towards greater engagement in their personal or family healthcare process.
New research from the University of Bristol shows that the experiences of work and family life for women in the UK have become increasing polarised between those with further education and those without. Over time, the material advantages of better-educated mothers, for themselves and for their children, have been increasing.
A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings, according to a study presented October 19, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sue C Eng, MD Po Box 34888, Seattle, WA 98124-1888 Ph: (425) 977-4620 | Sue C Eng, MD 11800 Ne 128th St, Suite 100, Kirkland, WA 98034-7208 Ph: (425) 899-4500 |
News Archive
The Cautious Patient Foundation, the outreach and educational arm of PatientAlwaysFirst, a nonprofit organization committed to educating and empowering patients in the quest for quality health care, today announces a new grants program to support initiatives that successfully move patients towards greater engagement in their personal or family healthcare process.
New research from the University of Bristol shows that the experiences of work and family life for women in the UK have become increasing polarised between those with further education and those without. Over time, the material advantages of better-educated mothers, for themselves and for their children, have been increasing.
A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings, according to a study presented October 19, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
› Verified 8 days ago
David H Lee, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11800 Ne 128th St, Suite 100, Kirkland, WA 98034 Phone: 425-899-4500 Fax: 425-899-4510 | |
Mark R Vossler, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 | |
William S Getchell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 | |
Erin-siobhain Ross Currin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-3181 | |
Dr. James A. Lund, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12910 Totem Lake Blvd Ne, Suite 101, Kirkland, WA 98034 Phone: 425-814-5000 | |
Ronald W Yeh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11800 Ne 128th St, Suite 100, Kirkland, WA 98034 Phone: 425-899-4500 Fax: 425-899-4510 | |
Dr. Sarah P. Rougier, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St # Ms 105, Kirkland, WA 98034 Phone: 425-899-2563 |